Structure, function and clinical significance of transferrin receptors

被引:113
作者
Feelders, RA
Kuiper-Kramer, EPA
van Eijk, HG
机构
[1] Univ Rotterdam Hosp, Dept Internal Med 1, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus Univ, Dept Chem Pathol, Rotterdam, Netherlands
[3] Sophia Hosp, Clin Chem Lab, Zwolle, Netherlands
关键词
(serum) transferin receptor; ferritin; iron homeostasis; iron deficiency; anaemia of chronic disease;
D O I
10.1515/CCLM.1999.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Iron plays an essential role in a spectrum of metabolic processes. Cellular iron uptake is facilitated by transferrin receptor (TfR)-mediated endocytosis. in recent years more insight has been obtained in TfR physiology and the regulation of cellular iron homeostasis. The synthesis of TfR and the iron storage protein ferritin is regulated reciprocally at the post-transcriptional level according to the cellular iron status. As a result of externalization of TfR during the endocytic cycle, a soluble form of TfR can be detected in serum. The serum TfR (sTfR) level is closely related to erythroid TfR turnover and the prime determinants of the sTfR concentration are cellular iron demands and erythroid proliferation rate. In the absence of a hyperplastic erythropoiesis the sTfR level is a sensitive parameter of early tissue iron deficiency. The entire spectrum of body iron status can be assessed by measurement of serum ferritin and sTfR levels, with ferritin as marker of tissue iron stores and sTfR as index of tissue iron needs. The sTfR may be a promising tool to detect iron deficiency in inflammatory states and in the anaemia of chronic disease as its concentration is, in contrast to ferritin levels, not influenced by the acute phase response. Determination of sTfR levels may also improve assessment of body iron stores during pregnancy and in neonates. Finally, the sTfR may be a useful parameter to monitor erythropoiesis in various clinical settings, for instance in the prediction of the haematological response to erythropoietin treatment. However, standardization of the sTfR assay, with definition of reference and pathological ranges, is necessary for the definitive introduction of the sTfR as major parameter of iron metabolism.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 93 条
  • [1] Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure
    Ahluwalia, N
    Skikne, BS
    Savin, V
    Chonko, A
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) : 532 - 541
  • [2] Allen J, 1998, CLIN CHEM, V44, P35
  • [3] A NEW ROLE FOR THE TRANSFERRIN RECEPTOR IN THE RELEASE OF IRON FROM TRANSFERRIN
    BALI, PK
    ZAK, O
    AISEN, P
    [J]. BIOCHEMISTRY, 1991, 30 (02) : 324 - 328
  • [4] BAYNES RD, 1994, ADV EXP MED BIOL, V356, P61
  • [5] QUANTITATIVE ASSESSMENT OF ERYTHROPOIESIS IN HEMODIALYSIS-PATIENTS DEMONSTRATES GRADUAL EXPANSION OF ERYTHROBLASTS DURING CONSTANT TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BEGUIN, Y
    LOO, M
    RZIK, S
    SAUTOIS, B
    LEJEUNE, F
    RORIVE, G
    FILLET, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) : 17 - 23
  • [6] BEGUIN Y, 1993, BLOOD, V81, P1067
  • [7] Beguin Y, 1998, SEMIN ONCOL, V25, P27
  • [8] BEGUIN Y, 1989, J LAB CLIN MED, V113, P346
  • [9] BENTLEY DP, 1985, CLIN HAEMATOL, V14, P613
  • [10] SERUM FERRITIN AND BONE-MARROW IRON IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BLUMBERG, AB
    MARTI, HRM
    GRABER, CG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (24): : 3317 - 3319